162 related articles for article (PubMed ID: 38720951)
21. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
Therriault J; Servaes S; Tissot C; Rahmouni N; Ashton NJ; Benedet AL; Karikari TK; Macedo AC; Lussier FZ; Stevenson J; Wang YT; Fernandez-Arias J; Stevenson A; Socualaya KQ; Haeger A; Nazneen T; Aumont É; Hosseini A; Rej S; Vitali P; Triana-Baltzer G; Kolb HC; Soucy JP; Pascoal TA; Gauthier S; Zetterberg H; Blennow K; Rosa-Neto P
Alzheimers Dement; 2023 Nov; 19(11):4967-4977. PubMed ID: 37078495
[TBL] [Abstract][Full Text] [Related]
22. Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.
Karikari TK; Emeršič A; Vrillon A; Lantero-Rodriguez J; Ashton NJ; Kramberger MG; Dumurgier J; Hourregue C; Čučnik S; Brinkmalm G; Rot U; Zetterberg H; Paquet C; Blennow K
Alzheimers Dement; 2021 May; 17(5):755-767. PubMed ID: 33252199
[TBL] [Abstract][Full Text] [Related]
23. Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays.
Leuzy A; Janelidze S; Mattsson-Carlgren N; Palmqvist S; Jacobs D; Cicognola C; Stomrud E; Vanmechelen E; Dage JL; Hansson O
Neurology; 2021 Oct; 97(17):e1681-e1694. PubMed ID: 34493616
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylated tau in Alzheimer's disease.
Telser J; Grossmann K; Wohlwend N; Risch L; Saely CH; Werner P
Adv Clin Chem; 2023; 116():31-111. PubMed ID: 37852722
[TBL] [Abstract][Full Text] [Related]
25. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.
Dickerson BC; Wolk DA;
Front Aging Neurosci; 2013; 5():55. PubMed ID: 24130528
[TBL] [Abstract][Full Text] [Related]
26. Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline.
Mielke MM; Aakre JA; Algeciras-Schimnich A; Proctor NK; Machulda MM; Eichenlaub U; Knopman DS; Vemuri P; Graff-Radford J; Jack CR; Petersen RC; Dage JL
Alzheimers Dement; 2022 Apr; 18(4):602-611. PubMed ID: 34310832
[TBL] [Abstract][Full Text] [Related]
27. Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease.
Lim YY; Maruff P; Barthélemy NR; Goate A; Hassenstab J; Sato C; Fagan AM; Benzinger TLS; Xiong C; Cruchaga C; Levin J; Farlow MR; Graff-Radford NR; Laske C; Masters CL; Salloway S; Schofield PR; Morris JC; Bateman RJ; McDade E;
JAMA Neurol; 2022 Mar; 79(3):261-270. PubMed ID: 35099506
[TBL] [Abstract][Full Text] [Related]
28. Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer's pathology.
Therriault J; Ashton NJ; Pola I; Triana-Baltzer G; Brum WS; Di Molfetta G; Arslan B; Rahmouni N; Tissot C; Servaes S; Stevenson J; Macedo AC; Pascoal TA; Kolb HC; Jeromin A; Blennow K; Zetterberg H; Rosa-Neto P; Benedet AL
EBioMedicine; 2024 Apr; 102():105046. PubMed ID: 38471397
[TBL] [Abstract][Full Text] [Related]
29. Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels.
Murray ME; Moloney CM; Kouri N; Syrjanen JA; Matchett BJ; Rothberg DM; Tranovich JF; Sirmans TNH; Wiste HJ; Boon BDC; Nguyen AT; Reichard RR; Dickson DW; Lowe VJ; Dage JL; Petersen RC; Jack CR; Knopman DS; Vemuri P; Graff-Radford J; Mielke MM
Mol Neurodegener; 2022 Dec; 17(1):85. PubMed ID: 36575455
[TBL] [Abstract][Full Text] [Related]
30. Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies.
Mattsson-Carlgren N; Collij LE; Stomrud E; Pichet Binette A; Ossenkoppele R; Smith R; Karlsson L; Lantero-Rodriguez J; Snellman A; Strandberg O; Palmqvist S; Ashton NJ; Blennow K; Janelidze S; Hansson O
JAMA Neurol; 2024 Jan; 81(1):69-78. PubMed ID: 38048096
[TBL] [Abstract][Full Text] [Related]
31. Cerebrovascular disease drives Alzheimer plasma biomarker concentrations in adults with Down syndrome.
Edwards NC; Lao PJ; Alshikho MJ; Ericsson OM; Rizvi B; Petersen ME; O'Bryant S; Flores-Aguilar L; Simoes S; Mapstone M; Tudorascu DL; Janelidze S; Hansson O; Handen BL; Christian BT; Lee JH; Lai F; Rosas HD; Zaman S; Lott IT; Yassa MA; Gutierrez J; Wilcock DM; Head E; Brickman AM
medRxiv; 2023 Nov; ():. PubMed ID: 38076904
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS).
Liu Z; Shi D; Cai Y; Li A; Lan G; Sun P; Liu L; Zhu Y; Yang J; Zhou Y; Guo L; Zhang L; Deng S; Chen S; Yu X; Chen X; Zhao R; Wang Q; Ran P; Xu L; Zhou L; Sun K; Wang X; Peng Q; Han Y; Guo T
Alzheimers Res Ther; 2024 Apr; 16(1):84. PubMed ID: 38627753
[TBL] [Abstract][Full Text] [Related]
33. The Relationship of MRI-Derived Alzheimer's and Cerebrovascular-Related Signatures With Level of and Change in Health and Financial Literacy.
Lamar M; Arfanakis K; Yu L; Kapasi A; Duke Han S; Fleischman DA; Bennett DA; Boyle P
Am J Geriatr Psychiatry; 2023 Dec; 31(12):1129-1139. PubMed ID: 37541932
[TBL] [Abstract][Full Text] [Related]
34. Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.
Kac PR; González-Ortiz F; Emeršič A; Dulewicz M; Koutarapu S; Turton M; An Y; Smirnov D; Kulczyńska-Przybik A; Varma VR; Ashton NJ; Montoliu-Gaya L; Camporesi E; Winkel I; Paradowski B; Moghekar A; Troncoso JC; Lashley T; Brinkmalm G; Resnick SM; Mroczko B; Kvartsberg H; Gregorič Kramberger M; Hanrieder J; Čučnik S; Harrison P; Zetterberg H; Lewczuk P; Thambisetty M; Rot U; Galasko D; Blennow K; Karikari TK
Nat Commun; 2024 Mar; 15(1):2615. PubMed ID: 38521766
[TBL] [Abstract][Full Text] [Related]
35. Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios.
Janelidze S; Barthélemy NR; He Y; Bateman RJ; Hansson O
JAMA Neurol; 2023 May; 80(5):516-522. PubMed ID: 36987840
[TBL] [Abstract][Full Text] [Related]
36. Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology.
Ossenkoppele R; Salvadó G; Janelidze S; Binette AP; Bali D; Karlsson L; Palmqvist S; Mattsson-Carlgren N; Stomrud E; Therriault J; Rahmouni N; Rosa-Neto P; Coomans EM; van de Giessen E; van der Flier WM; Teunissen CE; Jonaitis EM; Johnson SC; ; Villeneuve S; Benzinger TLS; Schindler SE; Bateman RJ; Doecke JD; Doré V; Feizpour A; Masters CL; Rowe C; Wiste HJ; Petersen RC; Jack CR; Hansson O
medRxiv; 2024 Jun; ():. PubMed ID: 38947004
[TBL] [Abstract][Full Text] [Related]
37. Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.
Palmqvist S; Tideman P; Cullen N; Zetterberg H; Blennow K; ; Dage JL; Stomrud E; Janelidze S; Mattsson-Carlgren N; Hansson O
Nat Med; 2021 Jun; 27(6):1034-1042. PubMed ID: 34031605
[TBL] [Abstract][Full Text] [Related]
38. The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease.
Mohs RC; Beauregard D; Dwyer J; Gaudioso J; Bork J; MaGee-Rodgers T; Key MN; Kerwin DR; Hughes L; Cordell CB;
Alzheimers Dement; 2024 Apr; 20(4):2752-2765. PubMed ID: 38415908
[TBL] [Abstract][Full Text] [Related]
39. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
Bakkour A; Morris JC; Dickerson BC
Neurology; 2009 Mar; 72(12):1048-55. PubMed ID: 19109536
[TBL] [Abstract][Full Text] [Related]
40. A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.
Gonzalez-Ortiz F; Ferreira PCL; González-Escalante A; Montoliu-Gaya L; Ortiz-Romero P; Kac PR; Turton M; Kvartsberg H; Ashton NJ; Zetterberg H; Harrison P; Bellaver B; Povala G; Villemagne VL; Pascoal TA; Ganguli M; Cohen AD; Minguillon C; Contador J; Suárez-Calvet M; Karikari TK; Blennow K
Alzheimers Dement; 2024 Feb; 20(2):1239-1249. PubMed ID: 37975513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
